切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2021, Vol. 15 ›› Issue (02) : 144 -147. doi: 10.3877/cma.j.issn.1674-3253.2021.02.013

所属专题: 文献

临床研究

经尿道柱状水囊前列腺扩开术治疗高危前列腺增生患者的临床研究
张翼飞1,(), 张华2, 尹水平1, 梁朝朝1   
  1. 1. 230022 合肥,安徽医科大学第一附属医院泌尿外科
    2. 236600 安徽阜阳,太和县人民医院泌尿外科
  • 收稿日期:2020-05-11 出版日期:2021-04-01
  • 通信作者: 张翼飞

Clinical research of transurethral columnar balloon dilation of prostate in the treatment of high-risk benign prostatic hyperplasia

Yifei Zhang1,(), hua Zhang2, Shuiping Yin1, Chaozhao Liang1   

  1. 1. Department of Urology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
    2. Department of Urology, Taihe County Hospital, Anhui Fuyang 236600, China
  • Received:2020-05-11 Published:2021-04-01
  • Corresponding author: Yifei Zhang
引用本文:

张翼飞, 张华, 尹水平, 梁朝朝. 经尿道柱状水囊前列腺扩开术治疗高危前列腺增生患者的临床研究[J]. 中华腔镜泌尿外科杂志(电子版), 2021, 15(02): 144-147.

Yifei Zhang, hua Zhang, Shuiping Yin, Chaozhao Liang. Clinical research of transurethral columnar balloon dilation of prostate in the treatment of high-risk benign prostatic hyperplasia[J]. Chinese Journal of Endourology(Electronic Edition), 2021, 15(02): 144-147.

目的

探讨经尿道柱状水囊前列腺扩开术治疗高危前列腺增生患者的临床疗效。

方法

回顾性分析2016年6月至2018年7月我科收治的50例高危前列腺增生患者的临床资料,分成治疗组23例,对照组27例,治疗组采用新手术方式经尿道柱状水囊前列腺扩开术治疗。对照组采用经尿道前列腺等离子电切术,比较两组的手术时间、血红蛋白丢失量、持续膀胱冲洗时间、导尿管留置时间、并发症发生率及术后住院时间。术后随访观察比较两组生活质量评分(QOL)、国际前列腺症状评分(IPSS),最大尿流率(Qmax)、残余尿(RUV)等指标。

结果

手术均获成功,治疗组平均手术时间较对照组短[(16±4) min vs (97±11) min,P=0.001],手术组血红蛋白丢失量较对照组少[(19±4)g/L vs (75±8)g/L,P=0.017],持续膀胱冲洗时间较对照组缩短[(1.21±0.14)d vs (3.77±0.52)d,P=0.046],但导尿管留置时间和术后住院时间均高于对照组。术后随访3~12个月,QOL、IPSS、Qmax、RUV与对照组比较差异无统计学意义(P>0.05)。

结论

经尿道柱状水囊前列腺扩开术治疗前列腺增生,操作便捷、创伤小,手术时间短,对于高危前列腺增生患者,可以有限推广。

Objective

To investigate the clinical efficacy of transurethral columnar balloon dilation of prostate for high-risk patients with benign prostatic hyperplasia (BPH).

Methods

The data of 50 high-risk BPH patients admitted to our department From June 2016 to July 2018 were analyzed retrospectively. The patients were divided into the treatment group (23 cases) and the control group (27 cases). Transurethral columnar balloon dilation of prostate was performed in the treatment group, and transurethral plasma kinetic resection of prostate was performed in the control group. The operation time, intraoperative hemoglobin loss, continuous bladder irrigation time, catheter retention time, complication rate and the length of postoperative hospitalization were compared between the two groups. The postoperative quality of life (QOL), the international prostate symptom score (IPSS), maximum urinary flow rate (Qmax) and residual urine volume (RUV) were compared.

Result

All patients were operated successfully. The average operation time in the treatment group was shorter than that of the control group [(16±4) min vs (97±11) min, P=0.001]. The loss of hemoglobin in the treatment group was less than that of the control group [(19±4) g/L vs (75±8) g/L, P=0.017], and the continuous bladder irrigation time was shorter than that of the control group [(1.21±0.14) d vs (3.77±0.52) d, P=0.046]. However, the length of catheter retention and postoperative hospitalization in the treatment group were longer than those in the control group. There was no difference in the post-operative QOL, IPSS, Qmax and RUV during 3 to 12 months follow-up.

Conclusion

Transurethral columnar balloon dilation of prostate is an effective supplement for the treatment of high-risk BPH patients as a result of short operation time, less hemoglobin loss and optimized operation process.

表1 两组前列腺增生患者术前临床数据比较
表2 两组BPH患者手术及术后情况比较(±s
表3 两组BPH患者术后并发症比较(例)
表4 两组患者术后排尿相关指标随访结果比较
[1]
黄卫国,刘锋,张裕. 柱状水囊扩开术治疗高危高龄良性前列腺增生[J]. 江苏医药, 2012, 28(23): 2868-2869.
[2]
侯淑均,刘红珍,高博, 等. 经尿道柱状水囊前列腺扩开术与经尿道前列腺电切术的对比研究[J]. 中华全科医学, 2017, 15(3): 542-544.
[3]
何兆飞,施东辉,吴红华. 经尿道前列腺等离子电切术治疗大体积高危前列腺增生的临床分析[J]. 国际泌尿系统杂志, 2013, 33(3): 355-358.
[4]
张翼飞,尹水平,梁朝朝. 经尿道前列腺等离子整块剜除术治疗超大体积高危前列腺增生的临床分析[J]. 现代泌尿生殖肿瘤杂志, 2019, 11(5): 301-302.
[5]
王充,刘贤奎,苗晓林, 等. 电切镜测量辅助柱状水囊前列腺扩裂术治疗高龄高危前列腺增生[J]. 中国医科大学学报, 2017, 46(10): 952-954.
[6]
陈禹杰,何云峰,张尧, 等. 经尿道柱状水囊前列腺扩开术治疗中年及高危患者良性前列腺增生[J]. 重庆医学, 2017, 46(32): 4523-4525.
[7]
Mahmood SN, Aghaways I. Safety of ovemight hospitalization after transurethral resection of prostate[J]. Open J Urol, 2016, 6(1): 1-6.
[8]
Kardasevic A, Milicevic S. The correlation between prostate volume in patients with benign prostatic hyperplasiain relation to erectile dysfunction[J]. Med Arch, 2016, 70(6): 449-452.
[9]
Kim HJ, Sun HY, Choi H, et a1. Efficacy and safety of initial combination treatment of an alpha blocker with an anticholinergic medication in benign prostatic hyperplasia patients with lower urinary tract symptoms: updated Meta-Analysis[,J]. PLoS One, 2017, 12(1): e0169248.
[10]
查金智,吴永平,黄石辰, 等. 局部麻醉下行棒状水囊前列腺扩开术治疗前列腺增生[J]. 中国实用医药, 2018, 13(28): 51-52
[11]
卜威振,曾胜,任力娟, 等. 经尿道柱状水囊前列腺扩开术的研究进展[J]. 临床泌尿外科杂志, 2019, 34(1): 74-76.
[12]
Gandaglia G, Zaffuto E, Fossati NA, et a1. The role of prostatic inflammation in the development and progression of benign and malignant diseases[J]. Curr opinUrol, 2017, 27(2): 99-106.
[13]
王琪,李朝坤,黄亮. 经尿道柱状水囊扩开术治疗高危老年前列腺患者的分析[J]. 中华老年多器官疾病杂志, 2017, 16(6): 423-427.
[14]
孔庆阔,时景伟,刘宾, 等. 经尿道柱状水囊前列腺扩开术治疗老年前列腺增生疗效观察[J]. 中华实验外科杂志, 2018, 35(2): 361-362.
[15]
李仁彪,赵峰,贺彦君, 等. 前列腺突入膀胱内距离对柱状水囊前列腺扩开术疗效的影响[J]. 中国医药与临床, 2017, 17(5): 636-639.
[16]
卜威振,王鑫,王东文, 等. 内镜辅助直视下经尿道柱状水囊前列腺扩开术的疗效分析[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2019, 13(3): 198-202.
[17]
王充,苗晓林,连文峰, 等. 超声引导下经尿道柱状水囊前列腺扩开术治疗前列腺增生[J]. 微创泌尿外科杂志, 2018, 7(4): 263-266.
[18]
周进. 经尿道柱状水囊前列腺扩开术在良性前列腺增生患者中的应用效果分析[J]. 浙江创伤外科, 2018, 23(5): 930-931.
[1] 熊风, 林辉煌, 陈晓波. 铥激光在泌尿外科中的临床应用及研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 533-536.
[2] 韩广玮, 申雪晴, 吴涵潇, 曹炎武, 唐黎明. 前列腺增生并轻度尿道狭窄行去外鞘半导体激光汽化剜除与等离子电切的比较[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 490-494.
[3] 李全喜, 唐辉军, 唐友杰, 杨飞. DISCO成像技术在前列腺增生与前列腺癌鉴别诊断中的应用价值[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 332-335.
[4] 赖良海, 赵伟, 肖云新, 杨伟明, 陈光耀. 1 470 nm激光"平均三分法"剜除术与等离子剜除术治疗前列腺增生的比较[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 252-256.
[5] 李国峰, 李显文, 周祥福, 何昊麟, 杜红兵, 宾开云. 单极滚珠电极与等离子行经尿道前列腺剜除术的比较[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 247-251.
[6] 游猛, 顾志文, 宋生生, 张贺庆, 詹河涓. 等离子电切术与钬激光剜除术治疗体积>80 ml前列腺增生的比较[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(01): 44-49.
[7] 邹志辉, 张礼刚, 胡永涛, 牛迪, 陈佳, 葛秦涛, 尹水平, 杨诚, 施浩强, 邰胜, 周骏, 郝宗耀, 梁朝朝. 无线智能高清内镜在经尿道双极等离子解剖性前列腺剜除术中的应用初探[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(01): 39-43.
[8] 顾志波, 苏倩, 陈建刚, 陆明. 低功率钬激光与等离子剜除治疗中等体积前列腺增生的比较[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(06): 496-500.
[9] 邹志辉, 张礼刚, 梁朝朝. 电外科和激光平台等技术在前列腺增生日间手术中的应用[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(06): 489-495.
[10] 万颂, 华伟, 兰红梅, 骆正馨, 万跃平. 前列腺钬激光整块剜除术与经尿道前列腺电切术治疗前列腺增生的比较[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(05): 427-431.
[11] 董毅, 杨濛, 王正, 江爱民, 张宗勤, 吴震杰, 王林辉, 徐红, 刘冰. 经尿道等离子杆状电极解剖性前列腺剜除术的手术经验与临床疗效[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(05): 413-418.
[12] 许立哲, 夏煜琦, 程帆. 前列腺尿道悬吊术治疗前列腺增生的进展[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(05): 385-388.
[13] 刘爽, 张彬, 原小斌, 胡雅玲, 吴晓琳, 王东文. 经尿道电切术、剜除术及扩裂术治疗前列腺增生远期并发症的研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(04): 377-380.
[14] 王德胜, 许存前, 甄帅. 三重改良技术的前列腺等离子剜除术对于尿控功能保护的临床研究[J]. 中华腔镜泌尿外科杂志(电子版), 2022, 16(04): 331-334.
[15] 张宁, 张梦菲, 邱建新, 高闫尧, 陈育, 高靖榆. 腹腔镜下经尿道等离子电切术联合疝环充填式无张力疝修补术治疗腹股沟斜疝合并前列腺良性增生[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(04): 441-444.
阅读次数
全文


摘要